Lv6
1660 积分 2022-02-15 加入
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
13天前
已完结
Allogeneic B7-H3-Targeted CAR Vδ1T-cell Therapy in Advanced Solid Tumors: A Phase I Study
22天前
已完结
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
30天前
已完结
Localized PD-1 CAR T therapy reprograms neuroinflammation
1个月前
已完结
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
2个月前
已完结
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity
2个月前
已完结
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy
6个月前
已完结
Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosis
6个月前
已完结
A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity
9个月前
已完结
Tonic signaling in CAR-T therapy: the lever long enough to move the planet
9个月前
已完结
皖公网安备34019202002308
